Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_000249.4(MLH1):c.207+5G>C variant causes a splice region, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
MLH1 (HGNC:7127): (mutL homolog 1) The protein encoded by this gene can heterodimerize with mismatch repair endonuclease PMS2 to form MutL alpha, part of the DNA mismatch repair system. When MutL alpha is bound by MutS beta and some accessory proteins, the PMS2 subunit of MutL alpha introduces a single-strand break near DNA mismatches, providing an entry point for exonuclease degradation. The encoded protein is also involved in DNA damage signaling and can heterodimerize with DNA mismatch repair protein MLH3 to form MutL gamma, which is involved in meiosis. This gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). [provided by RefSeq, Aug 2017]
MLH1 Gene-Disease associations (from GenCC):
Lynch syndrome
Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
Lynch syndrome 2
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
Muir-Torre syndrome
Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Orphanet
Our verdict: Pathogenic. The variant received 11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 3-36996714-G-C is Pathogenic according to our data. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-36996714-G-C is described in CliVar as Pathogenic/Likely_pathogenic. Clinvar id is 141132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
This variant causes a G to C nucleotide substitution at the +5 position of intron 2 of the MLH1 gene. A functional RNA study has shown that this variant causes out-of-frame skipping of exon 2, resulting in premature truncation (PMID: 27978560). This variant has been reported in two individuals affected with colorectal cancer that exhibited DNA mismatch repair deficient tumor pathology (PMID: 27978560, 32620519) and to cosegregate with disease in a family with multiple individuals affected with colorectal cancer (PMID: 27978560). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of MLH1 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Likely Pathogenic. -
Aug 15, 2024
Ambry Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
The c.207+5G>C intronic variant results from a G to C substitution 5 nucleotides after coding exon 2 in the MLH1 gene. This alteration has been reported in multiple individuals whose family history met Amsterdam criteria for Lynch syndrome and/or had a tumor that demonstrated high microsatellite instability with loss of MLH1 and PMS2 expression by immunohistochemistry (Pearlman R et al. JAMA Oncol. 2017;3(4):464-471; Marabelli M et al. Dig Liver Dis, 2020 Dec;52:1503-1511; Ambry internal data). Analysis of patient-derived RNA found that this alteration results in aberrant splicing leading to transcripts lacking coding exon 2 (Pearlman R et al. JAMA Oncol. 2017;3(4):464-471). In addition, this alteration co-segregates with HNPCC-related tumors in multiple families (Pearlman R et al. JAMA Oncol. 2017;3(4):464-471; Ambry internal data). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Lynch syndromePathogenic:1
Mar 25, 2016
University of Washington Department of Laboratory Medicine, University of Washington
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing;in vitro
RNA evidence indicating exon 2 skipping and familial co-segregation analysis indicated evidence for cosegregation of this variant with colon cancers that have loss of MLH1 on IHC (likelihood ratio 25.28, LOD: 1.4). Taken together this is sufficient evidence for variant pathogenicity. -